PLASMA-LEVELS AND URINARY-EXCRETION OF METHYL-GAG FOLLOWING IV INFUSION IN MAN
- 1 January 1981
- journal article
- research article
- Vol. 65 (3-4) , 253-257
Abstract
The pharmacokinetics of methyl-GAG [methylglyoxalbisguanylhydrazone] was studied after nephrectomy in 5 patients with renal cell carcinoma and in 1 patient with breast cancer. Following rapid infusion (30 min) of 700 mg/m2 of methyl-GAG, plasma concentrations declined in a biphasic mode with an apparent terminal half-life of 136-224 h. Drug levels declined to 6-20% of the initial plasma concentration in the first 24 h. Approximately 40% of the dose was recovered in the urine after 2 wk. Extensive extravascular distribution of methyl-GAG is suggested.This publication has 3 references indexed in Scilit:
- High-performance liquid chromatographic assay for methylglyoxal bis(guanylhydrazone) (methyl GAG) in plasma and urineJournal of Chromatography A, 1980
- Clinical Pharmacology of the Effective Antitumor DrugsAnnual Review of Pharmacology, 1965
- Treatment of acute leukemia with methylglyoxal‐bis‐guanylhydrazone (methyl GAG)Clinical Pharmacology & Therapeutics, 1965